Prevalence of hepatitis C and diabetes among chronic kidney diseases patients and their effects on renal functions

Authors

  • Azab Elsayed Azab Department of Zoology, Faculty of Science, Alejelat, Zawia University, Libya
  • Ata Sedik Ibrahim Elsayed Department of Biomedical Sciences, Faculty of Medicine, Dar Al Uloom University, Riyadh, Kingdom of Saudi Arabia

DOI:

https://doi.org/10.56511/JIPBS.2017.v4.i01.pp12-16

Abstract

Background: The prevalence of hepatitis C virus infection in developed countries is higher in patients undergoing dialysis and in patients with chronic kidney disease (CKD) than the general population. The hepatitis C virus mainly causes liver damage, but is also associated with extra-hepatic diseases, including various types of glomerulonephritis. Diabetic nephropathy is one of the most common complications of diabetes. The prevalence of diabetic nephropathy is increasing steeply along with the diabetes epidemic. Objective: This study aimed to discover the effects of HCV infection and diabetes in the progression of CKD. Methods: This study was conducted on 72 patients with chronic renal failure and 40 healthy persons as control. The study was performed in El-Zahraa hospital, Libya. Results: Most of patients were in stage five of CKD. By serological test for HCV, we found that, 31.1% of male and 28.9% of female patients are infected with hepatitis C virus and 48.75% of males and 42.1% of females were diabetic. The diabetic patients who infected with HCV were 14.3% of males and 26.3% of females. The patients who free from both diabetes and HCV were 20% of males and 20.3% of females. The diabetic patients showed also increase in serum creatinine, which is higher than the increase in the groups free from HCV and diabetes but lower than the groups of HCV infection, also urea levels in both diabetic and hepatitis groups were higher than levels in non-diabetic and negative for HCV serological test.

Keywords:

Chronic kidney diseases, CKD, HCV, Diabetes, Renal functions

Downloads

Download data is not yet available.

References

Noureddine LA, Usman SA, Yu, Z, Moorthi, RN, and Moe SM: Hepatitis C Increases the Risk of Progression of Chronic Kidney Disease in Patients with Glomerulonephritis. Am J Nephrol 2010; 32:311 – 316.

Chen Y, Chiou W, Hung S, Su Y and Hwang S: Hepatitis C virus itself is a causal risk factor for chronic kidney disease beyond traditional risk factors: a 6-year nationwide cohort study across Taiwan. BMC Nephrology 2013; 14:187.

Latt N, Alachkar N, and Gurakar A: Hepatitis C Virus and Its Renal Manifestations: A Review and Update. Gastroenterology & Hepatology 2012; 8(7):434-445.

Etik DO, Ocal S, and Boyacioglu AS: Hepatitis C infection in hemodialysis patients: A review. World J Hepatol 2015; 7(6): 885-895.

Lee JJ, Lin MY, Chang JS, Hung CC, Chang JM, Chen HC, Yu ML, Hwang SJ: Hepatitis C virus infection increases risk of developing endstage renal disease using competing risk analysis. PLoS One 2014; 9: e100790.

Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G: Metaanalysis: Effect of hepatitis C virus infection on mortality in dialysis. Aliment Pharmacol Ther. 2004; 20:1271-1277.

Noubiap JJ, Naidoo J, and Kengne AP: Diabetic nephropathy in Africa: A systematic review. World J Diabetes 2015; 6(5): 759-773.

Harjutsalo V, Groop PH: Epidemiology and risk factors for diabetic kidney disease. Adv Chronic Kidney Dis 2014; 21:260-266.

Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16:31-41.

Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, Held PJ, Young EW: Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003; 14:3270-3277.

Serfaty L, Capeau J: Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data. Liver Int. 2009; 29:13 – 25.

Harrison SA.: Insulin resistance among patients with chronic hepatitis C: etiology and impact on treatment. ClinGastroenterolHepatol 2008; 6:864 – 876.

Sarafidis PA, Ruilope LM: Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol. 2006; 26:232 – 244.

Iovanescu VF, Streba CT, Ionescu M, Constantinescu AF, Vere CC, Rogoveanu I, and Mo ț a E.: Diabetes mellitus and renal involvement in chronic viral liver disease. Journal of Medicine and Life 2015; 8(4):483487.

Ruster C and Wolf G.: The role of chemokines and chemokine receptors in diabetic nephropathy. Front Biosci 2008; 13: 944-955.

Iwano M, Plieth D, Danoff TM, Xue C, Okada H, and Neilson EG: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest. 2002; 110:341-350.

Published

05-01-2017
Statistics
251 Views | 144 Downloads

How to Cite

Azab, A. E., and A. S. I. Elsayed. “Prevalence of Hepatitis C and Diabetes Among Chronic Kidney Diseases Patients and Their Effects on Renal Functions”. Journal of Innovations in Pharmaceutical and Biological Sciences, vol. 4, no. 1, Jan. 2017, pp. 12-16, doi:10.56511/JIPBS.2017.v4.i01.pp12-16.

Issue

Section

Research Article